Prognostic value of pre-operative mean corpuscular volume (MCV) in colorectal cancer.
Colorectal cancer
Mean corpuscular volume
Recurrence
Survival
Journal
Irish journal of medical science
ISSN: 1863-4362
Titre abrégé: Ir J Med Sci
Pays: Ireland
ID NLM: 7806864
Informations de publication
Date de publication:
09 Nov 2023
09 Nov 2023
Historique:
received:
30
08
2023
accepted:
01
11
2023
medline:
9
11
2023
pubmed:
9
11
2023
entrez:
9
11
2023
Statut:
aheadofprint
Résumé
Mean corpuscular volume (MCV) has been shown to have some correlation to oncological outcomes in oesophageal cancer, with high pre-operative MCV associated with disease recurrence. A similar association has previously been reported in colorectal cancer. This study is aimed at investigating whether high MCV bears similar relation to post-operative outcome and disease recurrence in colorectal cancer (CRC). Patients undergoing elective CRC resection with curative intent between January 2008 and December 2019 were identified from our prospective database. Review of patient demographic details, American Society of Anaesthesiologists (ASA) grade, smoking and alcohol intake were performed. In addition, tumour location and staging, operation performed, pre-operative laboratory data and oncological management of each patient were noted. Post-operative morbidity (Clavien-Dindo (CD) score > 2), 30-day mortality, in-hospital mortality and cancer recurrence were examined and multivariable regression analysis was performed to predict these outcomes. A total of 1,293 CRCs were resected, with 1,159 patients (89.7%) experiencing a hospital course without major morbidity (CD < 3). 30-day mortality rate was less than 1% (12/1293). There were 176 patients (13.6%) with recurrence at follow-up. When multivariable regression analysis was performed, high pre-operative MCV did not predict negative post-operative or oncological outcomes. MCV does not appear to be an independent prognostic factor for outcomes following elective CRC resection.
Sections du résumé
BACKGROUND
BACKGROUND
Mean corpuscular volume (MCV) has been shown to have some correlation to oncological outcomes in oesophageal cancer, with high pre-operative MCV associated with disease recurrence. A similar association has previously been reported in colorectal cancer.
AIMS
OBJECTIVE
This study is aimed at investigating whether high MCV bears similar relation to post-operative outcome and disease recurrence in colorectal cancer (CRC).
METHODS
METHODS
Patients undergoing elective CRC resection with curative intent between January 2008 and December 2019 were identified from our prospective database. Review of patient demographic details, American Society of Anaesthesiologists (ASA) grade, smoking and alcohol intake were performed. In addition, tumour location and staging, operation performed, pre-operative laboratory data and oncological management of each patient were noted. Post-operative morbidity (Clavien-Dindo (CD) score > 2), 30-day mortality, in-hospital mortality and cancer recurrence were examined and multivariable regression analysis was performed to predict these outcomes.
RESULTS
RESULTS
A total of 1,293 CRCs were resected, with 1,159 patients (89.7%) experiencing a hospital course without major morbidity (CD < 3). 30-day mortality rate was less than 1% (12/1293). There were 176 patients (13.6%) with recurrence at follow-up. When multivariable regression analysis was performed, high pre-operative MCV did not predict negative post-operative or oncological outcomes.
CONCLUSION
CONCLUSIONS
MCV does not appear to be an independent prognostic factor for outcomes following elective CRC resection.
Identifiants
pubmed: 37943400
doi: 10.1007/s11845-023-03571-8
pii: 10.1007/s11845-023-03571-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.
Références
Dekker E, Tanis PJ, Vleugels JLA et al (2019) Colorectal cancer. The Lancet 394(10207):1467–1480
doi: 10.1016/S0140-6736(19)32319-0
He W, Yin C, Guo G et al (2013) Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol 30(1)
Ishizuka M, Nagata H, Takagi K et al (2013) Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br J Cancer 109(2):401–407
doi: 10.1038/bjc.2013.350
pubmed: 23820256
pmcid: 3721384
Monreal M, Fernandez-Llamazares J, Piñol M et al (1998) Platelet count and survival in patients with colorectal cancer – a preliminary study. Thromb Haemost 79(05):916–918
doi: 10.1055/s-0037-1615093
pubmed: 9609220
Rogers AC, Gibbons D, Hanly AM et al (2014) Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy. Mod Pathol 27(1):156–162
doi: 10.1038/modpathol.2013.124
pubmed: 23887296
Satomi A, Murakami S, Ishida K et al (1995) Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol 34(1):69–73
doi: 10.3109/02841869509093641
pubmed: 7532422
Aslinia F, Mazza JJ, Yale SH (2006) Megaloblastic anemia and other causes of macrocytosis. Clin Med Res 4(3):236–241
doi: 10.3121/cmr.4.3.236
pubmed: 16988104
pmcid: 1570488
Savage DG, Ogundipe A, Allen RH et al (2000) Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci 319(6):343–352
doi: 10.1016/S0002-9629(15)40772-4
pubmed: 10875288
Jomrich G, Hollenstein M, John M et al (2019) High mean corpuscular volume predicts poor outcome for patients with gastroesophageal adenocarcinoma. Ann Surg Oncol 26(4):976–985
doi: 10.1245/s10434-019-07186-1
pubmed: 30706229
pmcid: 6399169
Zheng Y-Z, Dai S-Q, Li W et al (2013) Prognostic value of preoperative mean corpuscular volume in esophageal squamous cell carcinoma. World J Gastroenterol 19(18):2811–2817
doi: 10.3748/wjg.v19.i18.2811
pubmed: 23687419
pmcid: 3653156
Nagai H, Yuasa N, Takeuchi E et al (2017) The mean corpuscular volume as a prognostic factor for colorectal cancer. Surg Today 48(2):186–194
doi: 10.1007/s00595-017-1575-x
pubmed: 28795308
Faiz O (2017) Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017) - audit and outcome reporting. Colorectal Dis 19:71–73
doi: 10.1111/codi.13707
pubmed: 28632313
Nakamura K, Seishima R, Matsui S et al (2022) The prognostic impact of preoperative mean corpuscular volume in colorectal cancer. Jpn J Clin Oncol 52(6):562–570
doi: 10.1093/jjco/hyac023
pubmed: 35253057
Sato R, Oikawa M, Kakita T et al (2022) Prognostic significance of the mean corpuscular volume (MCV) and red cell distribution width (RDW) in obstructive colorectal cancer patients with a stent inserted as a bridge to curative surgery. Surg Today 52(12):1699–1710
doi: 10.1007/s00595-022-02504-9
pubmed: 35441270
Beck N (2009) Macrocytosis: The macrocytic anemias. In. Diagnostic Hematology: Springer London 245–255
Unger KW, Johnson D (1974) Red blood cell mean corpuscular volume: a potential indicator of alcohol usage in a working population. Am J Med Sci 267(5):281–289
doi: 10.1097/00000441-197405000-00004
pubmed: 4833835
Brink M, Weijenberg MP, de Goeij AFPM et al (2004) Dietary folate intake and k-ras mutations in sporadic colon and rectal cancer in the Netherlands Cohort Study. Int J Cancer 114(5):824–830
doi: 10.1002/ijc.20775
Sato F, Meltzer SJ (2006) CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer 106(3):483–493
doi: 10.1002/cncr.21657
pubmed: 16362978